Bombesin staining in neuroendocrine cell hyperplasia of infancy (NEHI) and other childhood interstitial lung diseases (chILD)

Histopathology

Volumn 67, Issue 4, 2015, Pages 501-508

  Yancheva, Slaveya G ^a   Velani, Asha ^a   Rice, Alexandra ^a,b   Montero, Angeles ^a,b   Hansell, David M ^a,b   Koo, Sergio ^a   Thia, Lina ^c   Bush, Andrew ^a,b   Nicholson, Andrew G ^a,b  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bombesin; Children; Interstitial lung disease; Lung; Neuroendocrine cell hyperplasia of infancy

Indexed keywords

BOMBESIN; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; ARTICLE; CELL HYPERPLASIA; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLYCOGEN STORAGE DISEASE; HISTOLOGY; HUMAN; HUMAN TISSUE; INFANT; INTERSTITIAL LUNG DISEASE; LUNG BIOPSY; MALE; NEUROENDOCRINE CELL HYPERPLASIA OF INFANCY; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; STAINING; BIOSYNTHESIS; CHILD; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LUNG DISEASES, INTERSTITIAL; METABOLISM; NEUROSECRETORY CELL; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ADOLESCENT; BIOMARKERS; BOMBESIN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; LUNG DISEASES, INTERSTITIAL; MALE; NEUROENDOCRINE CELLS; RETROSPECTIVE STUDIES; STAINING AND LABELING;

EID: 84941598783     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12672     Document Type: Article

References (14)

1. Deutsch GH, Young LR, Deterding RR et al. Diffuse lung disease in young children: application of a novel classification scheme. Am. J. Respir. Crit. Care Med. 2007; 176; 1120-1128.
2. Rice A, Tran-Dang MA, Bush A et al. Diffuse lung disease in infancy and childhood: expanding the chILD classification. Histopathology 2013; 63; 743-755.
3. Deterding RR, Pye C, Fan LL et al. Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasia. Pediatr. Pulmonol. 2005; 40; 157-165.
4. Lukkarinen H, Pelkonen A, Lohi J et al. Neuroendocrine cell hyperplasia of infancy: a prospective follow-up of nine children. Arch. Dis. Child. 2013; 98; 141-144.
5. Gomes VC, Silva MC, Maia JH et al. Diagnostic criteria and follow-up in neuroendocrine cell hyperplasia of infancy: a case series. J. Bras. Pneumol. 2013; 39; 569-578.
6. Brody AS, Guillerman RP, Hay TC et al. Neuroendocrine cell hyperplasia of infancy: diagnosis with high-resolution CT. Am. J. Roentgenol. 2010; 194; 238-244.
7. Young LR, Brody AS, Inge TH et al. Neuroendocrine cell distribution and frequency distinguish neuroendocrine cell hyperplasia of infancy from other pulmonary disorders. Chest 2011; 139; 1060-1071.
8. Langston C, Dishop MK. Diffuse lung disease in infancy: a proposed classification applied to 259 diagnostic biopsies. Pediatr. Dev. Pathol. 2009; 12; 421-437.
9. Deterding RR, Fan LL, Morton R et al. Persistent tachypnea of infancy (PTI) - a new entity. Pediatr. Pulmonol. 2001; Suppl. 23; 72-73.
10. Soares JJ, Deutsch GH, Moore PE et al. Childhood interstitial lung diseases: an 18-year retrospective analysis. Pediatrics 2013; 132; 684-691.
11. Canakis AM, Cutz E, Manson D et al. Pulmonary interstitial glycogenosis: a new variant of neonatal interstitial lung disease. Am. J. Respir. Crit. Care Med. 2002; 165; 1557-1565.
12. Nicholson AG, Kim H, Corrin B et al. The value of classifying interstitial pneumonitis in childhood according to defined histological patterns. Histopathology 1998; 33; 203-211.
13. Young LR, Deutsch GH, Bokulic RE et al. A mutation in TTF1/NKX2.1 is associated with familial neuroendocrine cell hyperplasia of infancy. Chest 2013; 144; 1199-1206.
14. Rizvi SM, Goodwill J, Lim E et al. The frequency of neuroendocrine cell hyperplasia in patients with pulmonary neuroendocrine tumours and non-neuroendocrine cell carcinomas. Histopathology 2009; 55; 332-337.